CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-31 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −735 | 1,354,820 | ||
| 2023-01-31 | Schlanger David J Executive Chairman | Exercise or conversion | +1,285 | $0.91 | $1K | 76,001 |
| 2023-01-31 | Schlanger David J Executive Chairman | Sale | −1,285 | $35.00 | $45K | 74,716 |
| 2023-01-31 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −1,285 | 1,232,395 | ||
| 2023-01-25 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −259 | $32.78 | $8K | 58,968 |
| 2023-01-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −27,352 | $31.15 | $852K | 223,093 |
| 2023-01-03 | Schlanger David J Executive Chairman | Shares withheld for taxes | −7,832 | $31.15 | $244K | 74,716 |
| 2022-12-22 | Payson Norman Director | Sale | −6,617 | $30.89 | $204K | 272,446 |
| 2022-12-21 | Payson Norman Director | Sale | −6,617 | $31.65 | $209K | 279,063 |
| 2022-12-09 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −79 | $32.58 | $3K | 59,227 |
| 2022-12-08 | Payson Norman Director | Sale | −600 | $31.86 | $19K | 291,697 |
| 2022-12-08 | Payson Norman Director | Sale | −6,017 | $32.70 | $197K | 285,680 |
| 2022-12-07 | Payson Norman Director | Sale | −2,300 | $30.08 | $69K | 296,614 |
| 2022-12-07 | Payson Norman Director | Sale | −2,295 | $31.23 | $72K | 294,319 |
| 2022-12-07 | Payson Norman Director | Sale | −2,022 | $32.10 | $65K | 292,297 |
| 2022-12-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,691 | $36.63 | $62K | 62,303 |
| 2022-12-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale | −2,997 | $36.46 | $109K | 59,306 |
| 2022-11-29 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale | −14,801 | $36.70 | $543K | 63,994 |
| 2022-11-28 | Swartz Allison EVP, GC | Grant or award | +60,000 | 60,000 | ||
| 2022-11-28 | Swartz Allison EVP, GC | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 |
Page 33 of 77 · 1,524 trades